Rehan Verjee

Rehan Verjee is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Co-founder and CEO of Precede Biosciences since September 2021, Verjee's focus is on advancing precision medicine through innovative technology. Alongside this role, Verjee is a Strategic Advisor at Formation Bio, a Board Member at Tyra Biosciences and MassBio, and has held significant positions at EMD Serono, including President and Global Head of Innovative Medicines Franchises. Previous experience includes serving as EVP, Chief Marketing and Strategy Officer at Merck KGaA and Managing Director for Canada at EMD Serono. Verjee's educational background includes an MBioch in Molecular and Cellular Biochemistry from the University of Oxford.